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CoactivatorThe PGC-1 family of regulated coactivators, consisting of PGC-1α, PGC-1β and PRC, plays a central role in a
regulatory network governing the transcriptional control of mitochondrial biogenesis and respiratory
function. These coactivators target multiple transcription factors including NRF-1, NRF-2 and the orphan
nuclear hormone receptor, ERRα, among others. In addition, they themselves are the targets of coactivator
and co-repressor complexes that regulate gene expression through chromatin remodeling. The expression of
PGC-1 family members is modulated by extracellular signals controlling metabolism, differentiation or cell
growth and in some cases their activities are known to be regulated by post-translational modiﬁcation by the
energy sensors, AMPK and SIRT1. Recent gene knockout and silencing studies of many members of the PGC-1
network have revealed phenotypes of wide ranging severity suggestive of complex compensatory
interactions or broadly integrative functions that are not exclusive to mitochondrial biogenesis. The results
point to a central role for the PGC-1 family in integrating mitochondrial biogenesis and energy production
with many diverse cellular functions. This article is part of a Special Issue entitled: Mitochondria and
Cardioprotection.hondria and Cardioprotection.
l rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Mitochondria are membrane bound organelles that engage in
many important biological functions but are best known as the major
sites of oxidative energy production in eukaryotic cells [1,2].
According to the endosymbiont hypothesis, mitochondria arose
from the engulfment of aerobic eubacteria by a primordial anaerobic
eukaryote, an event that was possibly coincident with the origin of
eukaryotic cells [3]. Thus, the organelle has its own genetic system
that exhibits several prokaryotic features including a compact circular
DNA genome (mtDNA), multigenic RNA transcripts and bacteria-like
antibiotic sensitivity of the translational apparatus. Most of the
mitochondrial genes were lost to the nucleus leaving the organelle
with the capacity to encode only 13 proteins and the 22 tRNAs and 2
rRNAs required for their translation within the mitochondrial matrix
[4,5].
The limited coding capacity of mtDNA necessitates that nuclear
genes specify most proteins of the respiratory apparatus as well as
all of the enzymes required for other oxidative and biosynthetic
functions. Bi-genomic gene expression is required exclusively for the
respiratory apparatus and the translational machinery. All 13 proteins
encoded by mtDNA function as essential subunits of respiratory
complexes I, III, IV and V. These are expressed through the bi-directional synthesis of multigenic transcripts, followed by the
processing, polyadenylation and translation of individual mRNAs
[4,5]. Mitochondrial transcription requires a single RNA polymerase
(POLRMT), initiation (TFB2M) and stimulatory (Tfam) transcription
factors and a family of termination factors (mTERFs) [6,7]. In addition,
both nuclear and mitochondrial gene products depend upon a
complex series of import and assembly factors to direct them to the
correct mitochondrial subcompartment. These include the multi-
subunit outer and inner membrane receptor complexes that function
in conjunction with molecular chaperones to carry out the energy-
dependent import of proteins localized to both soluble andmembrane
compartments [8]. More specialized factors are also required for
proper assembly of the respiratory complexes imbedded in the inner
membrane [9].
Changes in mitochondrial mass have been documented in both
normal and disease states. For example, mitochondria differentiate
postnatally to acquire increased respiratory capacity as an adaptation
to oxygen exposure outside of the womb [10]. Mitochondrial
biogenesis increases in muscle cells upon exercise [11] or in response
to contraction induced by chronic electrical stimulation [12]. Thyroid
hormones have long been associated with increased mitochondrial
mass and the elevated expression of key metabolic enzymes and
respiratory cytochromes in responsive tissues [13,14]. Finally,
developmental signals induce the proliferation of mitochondria as
occurs in the brown fat of rodents and other mammals during
adaptive thermogenesis [15,16]. This review will focus on selective
aspects of the PGC-1 family regulatory network in mitochondrial
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the explosion of information on the PGC-1 coactivators in metabolic
regulation the review is not intended to be comprehensive.2. DNA Binding transcription factors in mitochondrial biogenesis
The ﬁrst vertebrate regulatory factors implicated in the global
expression of multiple mitochondrial functions were the nuclear
respiratory factors, NRF-1 and NRF-2 (Fig. 1). The properties of these
proteins have been reviewed and will not be considered in detail here
[7,17]. NRF-1 was identiﬁed through its binding to a palindromic
sequence in the cytochrome c promoter and has subsequently been
associated with the expression of many genes required for expression
and function of the respiratory chain. Similarly, NRF-2 was identiﬁed
as a multisubunit activator of cytochrome oxidase expression and the
human homolog of mouse GABP. The two factors frequently work in
conjunction in the expression of many nuclear genes specifying
essential mitochondrial functions [7,17,18]. Recent experiments have
implicated NRF-1 and NRF-2 in the in vivo control of all ten nucleus-
encoded cytochrome oxidase subunits [19,20].
Additional nuclear factors have been linked to the control of
mitochondrial respiratory function. The cAMP response element
binding protein, CREB, along with NRF-1 is involved in the growth-
regulated expression of cytochrome c [21–23]. The initiator element
binding factor, YY1, is engaged in both the positive and negative
control of certain cytochrome oxidase subunit genes [24,25]. Muscle-
speciﬁc COX genes depend upon MEF-2 and/or E-box consensus
elements for their tissue-speciﬁc expression [26]. Interestingly, NRF-1
regulates the expression of MEF-2A in muscle accounting for the
indirect NRF-1 control of muscle-speciﬁc COX subunits and other
muscle-speciﬁc MEF-2 target genes [27]. The orphan nuclear receptor,
ERRα (estrogen-related receptor), is abundantly expressed in highly
oxidative tissues and promotes β-oxidation through its control of the
medium chain acyl-coenzyme A dehydrogenase (MCAD) promoter
[28]. As shown in Fig. 1, ERRα is an important target in the control of
mitochondrial biogenesis by PGC-1α [29,30] and may provide a
regulatory link between fatty acid oxidation and the respiratory chain
[31]. Finally, c-myc is associated with the expression of certain NRF-1Fig. 1. Regulatory network governing mitochondrial functions orchestrated by PGC-1α.
mitochondrial biogenesis are depicted schematically. The diagram summarizes the regulati
with some of its target transcription factors involved inmetabolic regulation. Potential suppr
RIP140 co-repressor are also shown. The speciﬁc action of each regulatory factor or pathwatarget genes [32] and myc null ﬁbroblasts are deﬁcient in mitochon-
drial content [33].
Recent studies have highlighted a potential molecular switch from
c-myc-dependent mitochondrial oxidative phosphorylation to the
promotion of aerobic glycolysis by hopoxia inducible factor (HIF) in
cancer cells [34]. In this scheme, HIF-1, a transcriptional activator of
the glycolytic pathway, functions as a negative regulator of mito-
chondrial biogenesis and oxygen utilization in renal carcinoma cells
that lack the von Hippel–Lindau tumor suppressor (VHL). VHL is a
negative regulator of HIF-1and its absence in carcinoma promotes the
activation of the HIF pathway leading to enhanced glycolysis and the
up regulation of pyruvate dehydrogenase kinase 1. This kinase inhibits
the conversion of pyruvate to acetyl-CoA by pyruvate dehydrogenase
resulting in decreasedmitochondrial respiration. HIF-1 activation also
promotes the HIF-dependent inhibition of c-myc transcription and
degradation by the proteosome pathway [34]. Since c-myc is a
positive regulator of PGC-1β, its repression by HIF-1 results in the
inhibition of mitochondrial biogenesis and oxidative phosphorylation.
Interestingly, the human VHL promoter region has a perfect canonical
NRF-1 recognition site suggesting that its expression is under NRF-1
control [35]. Since, NRF-1 is a target for all of the PGC-1 family
coactivators (see below), the PGC-1–NRF-1 pathway may promote
mitochondrial oxidativemetabolism in part through the up regulation
of VHL expression (Fig. 1).
3. Phenotypes associated with the loss of essential mitochondrial
functions
Much has been learned of the consequences associated with the
loss of essential mitochondrial functions resulting from mtDNA
disease mutations or from ablation of nuclear genes required for the
maintenance of the respiratory apparatus. Striking proliferation of
abnormal mitochondria is observed in muscle ﬁbers from patients
with certain mitochondrial myopathies and similar changes have
been duplicated in mouse models of mitochondrial disease [36–38].
Moreover, homozygous knockout mice for several nuclear genes
whose products are localized to mitochondria and function in the
expression or maintenance of mtDNA have been generated. These
include Tfam, an mtDNA transcription and maintenance factor [39],Interactions among some key participants in the transcriptional network regulating
on of PGC-1α by transcriptional and post transcriptional pathways and its interactions
ession of glycolysis through NRF-1 control of VHL expression and negative control by the
y is discussed in the text.
Fig. 2. Arrangement of conserved domains among the PGC-1 family coactivators, PGC-
1α, PGC-1β and PRC. Schematic comparison of PGC-1α, PGC-1β and PRC with the
identities of the conserved sequence motifs shown in the key at the bottom.
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termination factor [41], and TFB1M, an RNA methyltransferase
involved in ribosome assembly [42]. In each case, germ line
homozygous null alleles result in embryonic lethality at approxi-
mately E8.5 accompanied by a severe respiratory chain deﬁciency. In
addition, the Tfam and PolgA null embryos were depleted of mtDNA
and the Tfam nulls exhibited increased numbers of aberrantly large
mitochondria with poorly deﬁned cristae. Cardiac-speciﬁc homozy-
gous knockouts were also constructed and analyzed for Tfam [43],
mTERF3 [41] and TFB1M [42]. In each case, the cardiac phenotype
exhibited a number of shared features. These include cardiomyopa-
thy, severe respiratory chain deﬁciency, defective assembly of
respiratory complexes containing mtDNA-encoded subunits (com-
plexes I, III, IV and V), and abundant, abnormal mitochondria with
poorly deﬁned cristae. Proliferation of abnormal mitochondria also
occurs inmouse knockouts of the heart/muscle isoform of the adenine
nucleotide translocator [36]. Thus, ablation of distinctly different
nuclear genes, whose products function exclusively within the mito-
chondria to maintain the respiratory apparatus, results in a number of
phenotypic similarities.
It is notable that homozygous null mice have also been generated
for most of the nuclear transcription factors implicated in the control
of mitochondrial biogenesis and none of them display the mitochon-
drial phenotype described above for nucleus-encoded factors that act
within themitochondria. Homozygous knockouts of several, including
NRF-1 [44], NRF-2(GABP) [45] and YY1 [46], are early embryonic or
preimplantation lethal, while others including ERRα [47] and PPARα
[48] are viable and fertile with no global changes in gross
mitochondrial number or morphology. NRF-1 null blastocysts exhibit
mitochondrial DNA depletion and loss of mitochondrial membrane
potential but likely have other non-mitochondrial defects that result
in blastocyst arrest and failure to progress to E8.5 [44]. PPARα null
mice have diminished expression of mitochondrial fatty acid
oxidation enzymes [48] while ERRα knockouts have reduced
lipogenesis and exhibit cold intolerance [47], but both are viable
and fertile with no gross phenotypic abnormalities. More recently, the
ERRα knockout mice were found to have reduced expression of
mitochondrial oxidative pathways including oxidative phosphoryla-
tion in brown adipose tissue accompanied by decreased mitochon-
drial mass [49]. This was associated with an inability to maintain body
temperature in response to cold exposure. The failure to observe
global changes in basal energy metabolism in these animals may
result from compensation by other regulators such as PGC-1α or ERRγ
[50]. C-Myc homozygous null mice are embryonic lethal between E9.5
and E10.5 [51] and c-myc has been implicated in the control of cell
cycle progression and metabolic networks [52]. These results suggest
that the individual effects of these transcription factors on mitochon-
drial biogenesis are either part of a broad, highly integrated function,
as in the case of early embryonic lethals, or serve to modulate the
existing mitochondrial complement in response to physiological
stress.
4. PGC-1α
PGC-1α is the founding member of a small family of structurally
related transcriptional coactivators comprised of PGC-1α, PGC-1β and
PRC (Fig. 2). PGC-1α and β share sequence similarities along their
entire lengths and have been linked to a wide range of biological
processes. Here, we will focus on their proposed role in nucleo-
mitochondrial interactions. PGC-1α was identiﬁed on the basis of its
induction during adaptive thermogenesis in brown fat and its
interaction with PPARγ, an important regulator of adipocyte differ-
entiation [53]. It lacks histone-modifying enzymatic activities but it
interacts, through a potent amino-terminal activation domain, with
an increasing number of coactivator complexes which contain
intrinsic chromatin remodeling activities [54,55]. These include SRC-1, CBP/p300 and GCN5, among others. The complexity of these
interactions, while poorly understood, is consistent with the hor-
monal and nutrient signaling pathways associated with PGC-1α
(Fig. 1). In addition to PPARγ, PGC-1α binds a large complement of
transcription factors and nuclear hormone receptors. Among those
directly associated withmitochondrial respiratory function are NRF-1,
ERRα, YY1, PPARα and MEF2C. Some of these act directly on the
expression of the respiratory chain (NRF-1, ERRα, YY1, MEF2C) while
others support the respiratory apparatus through their control of fatty
acid oxidation (PPARα, ERRα).
NRF-1 was an initial transcription factor target identiﬁed for the
induction of mitochondrial biogenesis by PGC-1α (Fig. 1). PGC-1α can
trans-activate NRF-1 target genes and a dominant negative allele of
NRF-1 blocks the effects of PGC-1α on mitochondrial biogenesis [56].
PGC-1α also targets estrogen-related receptor α (ERRα) in conjunc-
tion with GABPα (NRF-2α) in regulating respiratory genes including
cytochrome c and β-ATP synthase [29,30]. NRF-1 and NRF-2α
(GABPα) are thought to act downstream from both PGC-1α and
ERRα in mediating respiratory gene expression [30,57]. ERRα may
also exert direct control over GABPα transcriptional expression [30].
ERRα acts downstream from PGC-1α in orchestrating the program of
adaptive thermogenesis [29] and cooperates with ERRγ and
other transcription factors in driving the expression of a number of
metabolic genes essential to proper cardiac function [57]. Interest-
ingly, ERRα also stimulates the expression of the nuclear receptor
corepressor RIP140 during adipogenesis [58], suggesting a role for
ERRα in negative feedback control [59] (Fig. 1). RIP140 is known to
suppress both oxidative metabolism and mitochondrial biogenesis
through ERRα [60]. RIP140 also engages in a direct interaction with
PGC-1α in suppressing the ERRα and NRF-1-dependent expression of
CIDEA, a gene involved in both programmed cell death and meta-
bolism [61]. Thus, PGC-1α utilizes a network of positive and negative
transcriptional regulators in establishing and modulating metabolic
function (Fig. 1).
The proposed role for PGC-1α as a regulator of mitochondrial
biogenesis is supported by gain of function experiments in both
cultured cells [56] and transgenic mice [62]. In cultured cells, ectopic
PGC-1α expression increases COXIV and cytochrome c protein levels
as well as the steady-state level of mtDNA [56]. In mice, cardiac-
speciﬁc over expression in transgenic animals results in massive
increases in mitochondrial content in cardiac myocytes leading to
edema and dilated cardiomyopathy [62]. Over expression of PGC-1α
or βmay induce respiratory gene expression by overriding the ligand-
1272 R.C. Scarpulla / Biochimica et Biophysica Acta 1813 (2011) 1269–1278dependence of target nuclear receptors. In particular, thyroid
hormone receptors act as potent transcriptional repressors in the
absence of ligand through recruitment of a corepressor complex. This
repression is normally relieved by ligand binding resulting in the
recruitment of a coactivator complex that includes CBP/p300 [63].
Strong binding of over expressed PGC-1α or β to these receptors may
serve to displace the corepressor complex in the absence of ligand
leading to the induction of the many metabolic genes controlled by
thyroid hormones. Regardless of the mechanism, ectopic PGC-1α
expression may prove useful in ameliorating the bioenergetic
deﬁciency in mitochondrial myopathy [64].
More recently, metabolic signaling through PGC-1α was found to
occur through post-translational modiﬁcations (Fig. 1). For example,
nutrient sensing through the NAD+-dependent deacetylase, SITR1,
may function, in part, by deacetylating multiple lysine residues in
PGC-1α thereby promoting mitochondrial fatty acid oxidation in
response to low glucose [65]. Similarly, AMP-activated protein kinase
(AMPK), an enzyme sensor that is activated upon energy depletion in
muscle [66], phosphorylates PGC-1α on speciﬁc serine and threonine
residues. This results in increased mitochondrial gene expression
supporting the idea that AMPK can mediate at least some of its effects
through PGC-1α [67]. It is also apparent that the SIRT and AMPK
pathways can work together in mediating calcium dependent
mitochondrial proliferation in myocytes [68,69].5. PGC-1β
A homologue of PGC-1α was designated as PGC-1β or PERC
[70,71]. PGC-1α and β are closely related (Fig. 2) but PGC-1β lacks the
arginine/serine (R/S) domain that is associated with RNA processing
[70,72]. They are both enriched in tissues that contain abundant
mitochondria such as heart, skeletal muscle and brown fat but PGC-1β
is not induced in brown fat in response to cold exposure [70,71]. PGC-
1β also exhibits a marked preference for promoting the ligand-
dependent activity of ERα while having a minimal effect on ERβ [71].
Although initially implicated in liver gluconeogenesis [70], PGC-1β
was subsequently found to be a poor inducer of gluconeogenic genes
in liver and cultured hepatocytes because of its failure to interact with
hepatic nuclear receptor 4α (HNF4α) and forkhead transcription
factor O1 (FOXO1) [73,74]. However, PGC-1β appears identical to
PGC-1α in its functional interaction with NRF-1 and in its ability to
promote the expression of nuclear respiratory genes and mitochon-
drial mass when expressed from viral vectors [73,74]. Interestingly,
despite the functional similarities between the two family members,
PGC-1β promotes a much higher level of coupled respiration than
PGC-1α because of differences in proton leak suggesting differences
between the two in metabolic efﬁciency [75].
The functional differences between the two are further reﬂected
by the observation that loss of PGC-1α, while reducing the expression
of thermogenic genes, did not block brown fat differentiation [76]. In
fact, loss of either coactivator alone had little effect on differentiation-
induced mitochondrial biogenesis. However, silencing of PGC-1β in a
PGC-1α null background, while leaving basal levels of mitochondria
unaffected, completely abolished the increase in mitochondrial
number and function upon brown fat differentiation [76]. This is
indicative of complementary functions in promoting the differentiat-
ed state. The complementary role for these coactivators as differen-
tiation factors is also seen at the tissue level in the speciﬁcation of ﬁber
types in skeletal muscle. Over expression of PGC-1α in the skeletal
muscle of transgenic mice promotes the conversion to slow, oxidative
type I and IIA muscle ﬁbers [77]. By contrast, skeletal muscle over
expression of PGC-1β induces the speciﬁc formation of type IIX ﬁbers
which are highly oxidative but have fast twitch characteristics [78].
This was accompanied by the induction of oxidative phosphorylation
and fatty acid oxidation genes along with increased mitochondrialmass. Thus, in these gain of function experiments, the two factors can
execute distinct programs of ﬁber type differentiation.
6. In vivo functions of PGC-1α and β revealed by gene knockouts
Massive increases in mitochondrial content both in cultured
cells and in mouse tissues upon over expression of either PGC-1α or
PGC-1β is thought to occur through coactivator interactions with
key transcription factors (NRF-1, NRF-2, ERRα) in promoting the
expression of genes required for the biogenesis of mitochondria
[31,50,55,56,62,78,79]. Surprisingly, mice with a germ line targeted
disruption of PGC-1α are viable and exhibit normal mitochondrial
abundance and morphology in liver or brown fat [80]. A subtle
mitochondrial phenotype is reﬂected in diminished oxygen con-
sumption in isolated hepatocytes and lower steady-state levels of
several mRNAs required for mitochondrial function. Both the striatum
of the brain and brown adipose tissueweremorphologically abnormal
and the null mice were markedly hyperactive. This likely results from
the loss of striatal axons and reduced expression of respiratory and
brain-speciﬁc genes. Analysis of an independently constructed PGC-
1α null mouse conﬁrmed that the coactivator is not required for
normal development or for the global biogenesis or maintenance of
mitochondria [81]. It is important to note, however, that under
physiological stress the PGC-1α knockouts exhibit more severe
phenotypes such as an inability to defend body temperature in
response to cold and reduced cardiac ATP production andwork output
in response to physiological stimuli [80–82]. A skeletal muscle-
speciﬁc PGC-1α knockout mouse exhibited multiple muscle defects
including reduced exercise tolerance and abnormalities in the
maintenance of normal muscle ﬁber composition [83].
A similar theme is echoed in the construction and analysis of PGC-
1β knockouts. Two PGC-1β homozygous nulls [84,85] and one
homozygous hypomorphic variant that retains the partial ability to
trans-activate through ERRα [86], were generated independently. In
all three cases, the mice were viable and fertile and the homozygous
null animals had normal food intake, energy expenditure and
respiratory exchange ratios [85,86]. Thus, as with PGC-1α, the gene
encoding PGC-1β is nonessential and by itself does not function as an
absolute determinant of mitochondrial biogenesis. However, all of the
PGC-1β mice exhibited some level of mitochondrial dysfunction
especially under stress conditions. Although mitochondrial volume
density was only marginally affected in brown fat, mRNAs encoding a
number of nuclear respiratory genes were down regulated and the
animals exhibited deﬁciencies in thermoregulation. The fact that
elevated levels of PGC-1α mRNA in the brown fat of the PGC-1β
knockouts could not compensate for the loss of PGC-1β is consistent
with the conclusion that PGC-1β is not functionally redundant.
Interestingly, mitochondrial content was somewhat reduced in soleus
muscle and heart along with modest reductions in respiratory gene
expression. However, where measured, the mitochondria retained
normal internal structure and the respiratory function of isolated
mitochondria was indistinguishable between the wild type and
knockout animals [84–86]. The results support the idea that neither
coactivator alone is essential for viability or for the biogenesis of a
near normal complement of mitochondria. However, they each serve
to optimize mitochondrial function especially under conditions of
physiological stress.
Functional overlap between PGC-1α and β was recently revealed
by the construction and analysis of PGC-1α/β double knockout mice
[87]. These mice were viable at birth indicating that the absence of
both coactivators was compatible with a full course of prenatal
development. However, the majority died of cardiac failure within
24 hwith none surviving beyond 14 days. In contrast to the individual
knockouts, the mitochondrial volume density in the brown fat of the
PGC-1α/β double knockout was markedly reduced and the mito-
chondria exhibited diminished density of cristae coinciding with
Fig. 3. A model depicting the integration of mitochondrial and growth regulatory
functions by PRC. PRC is rapidly induced by serum stimulation of quiescent cells and
down regulated by serum withdrawal or contact inhibition. It binds both NRF-1 and
CREB in stimulating the expression of cytochrome c and other genes required for
mitochondrial function. It also engages in an indirect, functional interaction with NRF-2
through its binding of host cell factor (HCF). (Binding stoichiometry between NRF-2
and HCF has not been determined experimentally.) Regulation of PRC expression and
interactions among transcriptional regulatory factors are discussed in the text.
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cardiac failure was accompanied by mitochondrial abnormalities in
the heart marked by a reduction in mitochondrial number and size as
well as the presence of internal vacuoles with reduced cristae. These
differences resulted from a defect in mitochondrial maturation which
normally occurs during the late fetal and early postnatal stages
[10,88]. The expression of fatty acid oxidation and oxidative
phosphorylation genes were also diminished including a number of
ERRα and ERRγ target genes [87]. Since these factors are targets of the
PGC-1 coactivators it is likely that impairment of the PGC-1-ERR
pathway contributes to the mitochondrial maturation defect. These
results argue that the two coactivators provide complementary
functions in supporting postnatal cardiac differentiation.
7. PRC: black sheep of the family?
Because regulated coactivators are relatively rare, it was of interest
to identify additional PGC-1 family members that might respond to
alternative regulatory signals. A search for similarities to PGC-1α
identiﬁed a large partial cDNA containing a carboxy-terminal RS
domain and RNA recognition motif [89]. Molecular cloning of the full-
length cDNA revealed additional conserved sequence motifs
imbedded among otherwise dissimilar sequence (Fig. 2). These
included an acidic amino-terminal region, an LXXLL signature for
nuclear receptor coactivators and a central proline-rich region. Both
the sequence and spatial conservation of these motifs was highly
suggestive of related function. The encoded protein was thus
designated as PGC-1α-related coactivator (PRC) [89].
PRC resembles PGC-1α and β in its binding to nuclear transcription
factors associated with mitochondrial function including NRF-1, CREB
and ERRα [23,90]. NRF-1 and CREB binding to PRC was mapped to 34
amino acids located between the amino-terminal activation domain
and the proline-rich region and also to the R/S domain near the
carboxy terminus [23]. The signiﬁcance of the dual binding sites for
transcription factors is not known but may be required for coupling
transcription and RNA processing [72]. Immunoprecipitation experi-
ments conﬁrmed that antibodies directed against PRC could precip-
itate NRF-1 and CREB from cell extracts, indicating that these
molecules likely associate in vivo as well [23,89,90].
In addition to the carboxy-terminal R/S and RRM, PRC and PGC-1α
share an extremely potent, amino terminal, transcriptional activation
domain that is required for NRF-1-dependent trans-activation by PRC
[89]. PRC trans-activates a number of nuclear genes required for
mitochondrial respiratory function including cytochome c, 5-amino-
levulinate synthase, Tfam and themitochondrial transcription factor B
isoforms, TFB1M and TFB2M [89,91]. In each case, the functional NRF-
1 recognition sites are required for maximal promoter activation by
PRC [89,91]. PRC also utilizes CREB and NRF-2 sites for the activation
of cytochrome c and TFB promoters, respectively. In the latter case, a
head-to-head comparison demonstrated nearly identical require-
ments for activation of both TFB promoters by PRC and PGC-1α [91].
Despite these many similarities between PRC and the other PGC-1
family members there are also important differences that point to
distinct biological functions. In mouse, PGC-1α mRNA is abundantly
expressed in tissues with high mitochondrial content such as heart,
kidney and brown fat [53] in contrast to PRCmRNA, whose expression
does not appear to track mitochondrial abundance [89]. In addition,
PGC-1α mRNA is markedly induced in brown fat in response to cold
exposure in keeping with its role in adaptive thermogenesis [53]
whereas PRCmRNA shows little induction under these conditions [89].
Thus, unlike PGC-1α, PRC expression is not linked to the variations in
mitochondrial content associated with differentiated tissues.
Interestingly, as depicted in Fig. 3, PRC mRNA and protein are
expressed at higher levels in proliferating cells compared to those that
are growth arrested because of serum withdrawal or contact
inhibition [23,89]. PRC is also markedly induced upon serumstimulation of quiescent cells in the absence of de novo protein
synthesis, demonstrating that its rapid induction occurs through the
use of preexisting factors [23]. This property along with its relatively
short mRNA half life is shared by a class of genes known as the
immediate early genes. These genes include chemokines, growth
factors, proto-oncogenes, serine-threonine kinases, enzymes of
nucleic acid metabolism and transcription factors, among others
[92,93]. PRC is the only known transcriptional coactivator belonging
to this class of growth regulators suggesting a role for PRC in the
integration of respiratory chain expression with the cell growth
program (Fig. 3).
Serum induction of PRC is associatedwith a gene expression proﬁle
that is similar to that observed in response to elevated PGC-1α [91,94].
This includes increased expression of Tfam, TFB1M and 2 MmRNAs as
well as those for both nucleus and mitochondria encoded respiratory
subunits [94]. PRC, NRF-1 and Tfam are also elevated in thyroid
oncocytomas along with increases in cytochrome oxidase activity and
mtDNA content [95]. These thyroid tumors exhibit dense mitochon-
drial accumulation and are apparently lacking PGC-1α, suggesting that
PRC may drive mitochondrial proliferation in these tumors.
8. Host cell factor (HCF): a platform for PGC-1 coactivator-NRF-2
(GABP) interactions
Although both PRC and PGC-1α required NRF-2 binding sites for
maximal activation of target promoters, there was no direct binding of
the NRF-2α or β subunits to either coactivator in vitro. However,
antibodies directed against NRF-2α or β subunits could efﬁciently
immunoprecipitate PRC from cell extracts suggesting that PRC and
NRF-2 are bound to the same in vivo complex through one or more
intermediaries [90]. A candidate for such an intermediary is HCF (host
cell factor), a molecule that binds both NRF-2β(GABPβ) [96] and the
PGC-1 coactivators [70]. HCF is an abundant chromatin-associated
protein that was identiﬁed as a cellular factor required for herpes
virus immediate early gene expression [97] and for progression
through G1 of the cell cycle [98]. It associates with a number of
transcription factors including VP16 and NRF-2β(GABPβ) (Fig. 3) as
well as chromatin remodeling activities. Like the other PGC-1 family
1274 R.C. Scarpulla / Biochimica et Biophysica Acta 1813 (2011) 1269–1278coactivators [70], PRC binds HCF in vitro through a subfragment that
contains the consensus DHDY HCF binding motif [90]. Moreover,
antibodies directed against either PRC or HCF immunoprecipitate
NRF-2β from cell extracts. In fact, deletion of the DHDY HCF binding
site on PRC markedly reduced its ability to activate NRF-2-dependent
transcription [90]. Likewise, the same amino acid residues required
for HCF binding to the NRF-2β activation domain are also required for
NRF-2-dependent promoter activation by PRC. Moreover, all three
proteins have also been localized to the TFB1M and TFB2M promoters
by chromatin immunoprecipitation conﬁrming their association with
biologically relevant promoters. Thus, HCF functions as a common
platform for all three PGC-1 family members. The PGC-1 coactivators
may be limiting components of a higher order transcription complex
where HCF facilitates access to constitutively assembled transcription
factors and chromatin modifying activities.
9. PRC silencing supports a role in nucleo-mitochondrial
interactions
The similarities and differences between PGC-1α and PRC raise the
question of whether PRC is functionally equivalent to PGC-1α, differing
only in its responses to environmental signals. This appears not to be theFig. 4. Effects of PRC silencing on mitochondrial morphology and oxidative function. (Pane
control shRNA or PRC shRNA #1. Control shRNA transductants display a more rounded m
transductants display a ﬂattenedmorphology withmuchweaker cytochrome oxidase stainin
cells expressing either a control shRNA or PRC shRNAs associated with either complete (shRN
transductant is associated with abundant, atypical mitochondria lacking well-deﬁned cristacase. PRC displays only weak binding to nuclear hormone receptors and
this binding is not enhanced by ligand. In contrast, ligand enhances the
bindingof PGC-1α to bothTRβ andRAR in vitro [53,90]. PRC alsoexhibits
only very weak binding to PPARγ [90], a known target for PGC-1α [53].
Moreover, enhanced respiratory gene expression and mitochondrial
biogenesis upon over expression of PRC in cultured cells has not been
observed, although combined expressionwith ERRα does induce citrate
synthase and cytochrome oxidase activities [99]. This may reﬂect the
weak binding of PRC to nuclear hormone receptors.
Despite differences in gain of function experiments, PRC loss of
function in cultured cells results in defects in respiratory chain
expression and mitochondrial biogenesis. A subfragment of PRC that
binds both NRF-1 and CREB inhibits the PRC activation of the
cytochrome c promoter when present in trans. This same sub-
fragmentwhen stably expressed in lentiviral transductants also inhibits
respiratory growth on galactose [23], which requires mitochondrial
respiration and ATP production [100]. The results suggested that the
interaction between PRC and its target transcription factors may be
important for mitochondrial respiratory function in living cells [23].
A more deﬁnitive link between PRC and mitochondrial biogenesis
came from lentiviral transductants where PRC expression was
diminished by short hairpin RNAs (shRNAs). Lentiviral expression ofl A) Cytochrome oxidase staining of lentiviral transductants of U2OS cells expressing a
orphology with intense cytochrome oxidase staining of the cytoplasm. PRC shRNA#1
g. (Panel B) Electronmicrographs of mitochondria from lentiviral transductants of U2OS
A#1) or partial (shRNA#4) PRC silencing. Complete PRC silencing in the PRC shRNA #1
e.
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PRC sequences, resulted in either complete (shRNA1) or partial
(shRNA4) knockdown of PRC protein [101] in U2OS cells, where PRC
expression is growth regulated [23]. Although both partial and
complete PRC silencing resulted in growth inhibition in the G1/S
transition, complete PRC silencing by shRNA1 resulted in nearly
complete inhibition of growth on galactose. This was accompanied by
diminished expression of both nuclear and mitochondrial respiratory
chain subunits, lower levels of respiratory complexes I and IV (Fig. 4A)
and reduced production of mitochondrial ATP. Moreover, the shRNA1
transductant had abundant, morphologically defective mitochondria
marked by the absence of well-deﬁned cristae and a matrix space
devoid of internal structure (Fig. 4B). This phenotype is reminiscent of
that observed in the tissue-speciﬁc disruption of nuclear genes whose
products are localized to mitochondria and are required by the
mitochondrial genetic system [39,41,42]. The shRNA4 transductants,
despite having increased numbers of smaller mitochondria (Fig. 4B)
and a milder galactose growth defect, had no apparent deﬁcit in
respiratory chain expression and ATP production [101]. This indicates
that the reduced level of PRC in these cells (about 15% of wild type) is
sufﬁcient to maintain near normal mitochondrial content and
respiratory function. This low functional threshold may explain why
PRC over expression alone does not enhance mitochondrial content
and respiratory gene expression.
From the severity of themitochondrial defect onemight expect that
respiratory gene expression would be affected in the PRC knockdown.
Gene arrays revealed 79 mitochondria-related genes whose expression
was altered signiﬁcantly upon complete PRC silencing [101]. These
included respiratory chain subunits, mitochondrial protein import and
assembly factors, and mitochondrial ribosomal proteins and tRNA
synthetases, among others (Fig. 5). Approximately two thirds of the
genes were down regulated. Notably, nearly all of the genes involved inFig. 5. Summary of the effects of PRC silencing on the expression of genes required for
signiﬁcantly (pb0.01, FDR pb0.05) upon complete PRC silencing in lentiviral transductants
those down regulated are shown in red. Arrows point to a schematic representation of theprotein import and assembly, which were affected by PRC silencing,
showed reduced expression (Fig. 5). The diminished expression of
multiple genes in this category could have an adverse effect, not only on
the entire respiratorymachinery, but also on the import of enzymes and
other proteins necessary for the proper assembly of a functional
organelle. A small subset of mitochondria-related genes was affected
upon partial PRC silencing in keeping with the milder mitochondrial
phenotype. Transient PRC silencing by siRNA also affects the expression
of the respiratory chain at both the mRNA and protein level and was
most pronounced for complexes I, II and IV [102]. This provides
independent conﬁrmation that PRC acts as a positive regulator of the
mitochondrial respiratory complexes. Thus, blocking PRC function by
independentmeans, dominantnegative inhibition [23] and shRNA[101]
or siRNA [102] silencing results in a mitochondrial phenotype with
features similar to those observed in mouse knockouts of genes whose
products function exclusivelywithin themitochondria. It is important to
note that the severity of the mitochondrial phenotypes associated with
PRC silencing may result from the absence of detectable PGC-1α and β
expression in many cultured cell lines. It remains to be determined
whether the PGC-1 coactivators can compensate for the loss of PRC in
other physiological settings. Conversely, it has been suggested that PRC
may support embryogenesis in the PGC-1α/β double knockout mouse
[87].
10. Summary and perspective
The PGC-1 family coactivators are key components in the molecular
network that regulates the expression of the respiratory chain and the
biogenesis ofmitochondria. They engage inmultiple interactionswith a
complex array of transcriptional regulators and are modiﬁed post-
translationally in response to energy sensing pathways. Muchwork has
focused on these coactivators in the expression of nucleus encodedmitochondrial biogenesis and metabolic function. Genes whose expression is altered
are listed under each functional category. Those up regulated are shown in green while
mitochondrial functions affected.
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system. However, very little is known of their potential contributions to
the synthesis and assembly of the membrane architecture comprising
the mitochondrial reticulum itself. In addition, mouse knockouts have
revealed important distinctions among the various regulatory factors.
Homozygous knockouts of genes that function exclusively within the
mitochondria exhibit phenotypic similarities including respiratory
chain dysfunction and abundant abnormal mitochondria as is also
seen in a number of human mitochondrial diseases. This suggests that
the nuclear response to mitochondrial impairment at a number of sites
within mitochondria can be fairly uniform. By contrast, knockout of
individual components in the PGC-1 family regulatory network can
result in diverse phenotypes ranging from early embryonic lethality to
complete viability with very mild effects on global mitochondrial
content and function. This indicates that some factors provide a unique
and essential role that is not exclusive to mitochondria whereas others
engage in compensatory interactions, possibly among family members,
as illustrated by the PGC-1α/β double knockout. In either event, there
appears to be no single regulator whose sole function is to exert
exclusive control over mitochondrial content. Nevertheless, the PGC-1
family coactivators play a key role inmodulatingmitochondrial function
and energy homeostasis in a number of physiological settings. Further
understanding of the speciﬁc regulatory contributions of the three
family members will continue to provide important insights into the
control of mitochondrial energy metabolism during growth, differen-
tiation and disease.Acknowledgments
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